GR3017861T3 - A system for the controlled release of active agents and a process for its preparation. - Google Patents

A system for the controlled release of active agents and a process for its preparation.

Info

Publication number
GR3017861T3
GR3017861T3 GR950402965T GR950402965T GR3017861T3 GR 3017861 T3 GR3017861 T3 GR 3017861T3 GR 950402965 T GR950402965 T GR 950402965T GR 950402965 T GR950402965 T GR 950402965T GR 3017861 T3 GR3017861 T3 GR 3017861T3
Authority
GR
Greece
Prior art keywords
release
preparation
pharmaceutical
controlled
pharmaceutical preparation
Prior art date
Application number
GR950402965T
Other languages
English (en)
Inventor
Udo Prof Dr Sc Nat Wenzel
Juergen Doz Dr Sc Med Metzner
Thomas Dr Rosin
Halvor Dr Med Jaeger
Zoser B Dr Rer Nat Salama
Original Assignee
Int Pharma Agentur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25748261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3017861(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DD89325354A external-priority patent/DD295760A5/de
Priority claimed from DE19893932987 external-priority patent/DE3932987A1/de
Application filed by Int Pharma Agentur filed Critical Int Pharma Agentur
Publication of GR3017861T3 publication Critical patent/GR3017861T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Operation Control Of Excavators (AREA)
  • External Artificial Organs (AREA)
GR950402965T 1989-01-31 1995-10-25 A system for the controlled release of active agents and a process for its preparation. GR3017861T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DD89325354A DD295760A5 (de) 1989-01-31 1989-01-31 Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
DE19893932987 DE3932987A1 (de) 1989-10-03 1989-10-03 System fuer die kontrollierte freisetzung von wirkstoffen und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
GR3017861T3 true GR3017861T3 (en) 1996-01-31

Family

ID=25748261

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950402965T GR3017861T3 (en) 1989-01-31 1995-10-25 A system for the controlled release of active agents and a process for its preparation.

Country Status (13)

Country Link
EP (1) EP0381181B1 (el)
JP (1) JP2885858B2 (el)
AT (1) ATE126052T1 (el)
AU (1) AU641136B2 (el)
CA (1) CA2009045A1 (el)
DE (1) DE69021405T2 (el)
DK (1) DK0381181T3 (el)
ES (1) ES2078251T3 (el)
FI (1) FI900470A0 (el)
GR (1) GR3017861T3 (el)
HU (1) HU205851B (el)
IE (1) IE69174B1 (el)
NO (1) NO301520B1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
WO1996019974A1 (fr) * 1994-12-27 1996-07-04 Kanebo, Ltd. Preparation a liberation prolongee
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
US6074669A (en) * 1997-01-20 2000-06-13 Ranbaxy Laboratories Limited Controlled drug delivery system for diltiazem
JP4848101B2 (ja) * 2001-08-17 2011-12-28 株式会社フジモト・コーポレーション 徐放性マイクロペレット
RU2322233C2 (ru) * 2002-03-11 2008-04-20 Алькон, Инк. Имплантируемая система для доставки лекарственных средств
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
GB2150434B (en) * 1983-12-01 1987-11-04 Alza Corp Constant rate release systems
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form
EP0250374B1 (en) * 1986-06-17 1991-05-02 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. Therapeutic system for controlled release of drugs
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form

Also Published As

Publication number Publication date
DE69021405D1 (de) 1995-09-14
DK0381181T3 (da) 1995-10-30
NO301520B1 (no) 1997-11-10
CA2009045A1 (en) 1990-07-31
EP0381181B1 (en) 1995-08-09
FI900470A0 (fi) 1990-01-30
IE900336L (en) 1990-07-31
JP2885858B2 (ja) 1999-04-26
AU4898890A (en) 1990-08-09
EP0381181A3 (en) 1991-09-18
EP0381181A2 (en) 1990-08-08
HU900591D0 (en) 1990-04-28
JPH02282324A (ja) 1990-11-19
ES2078251T3 (es) 1995-12-16
IE69174B1 (en) 1996-08-07
AU641136B2 (en) 1993-09-16
NO900428L (no) 1990-08-01
DE69021405T2 (de) 1996-04-11
NO900428D0 (no) 1990-01-30
HUT53284A (en) 1990-10-28
ATE126052T1 (de) 1995-08-15
HU205851B (en) 1992-07-28

Similar Documents

Publication Publication Date Title
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
ZA878018B (en) Controlled release hydromorphone composition
IE790756L (en) Cerebral therapeutic agent
NO934768L (no) Sammensetning av L-DOPA-estere
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
DK1227806T3 (da) Farmaceutisk præparat indeholdende tolterodin og dets anvendelse
WO2002064148A3 (en) Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
GR3017861T3 (en) A system for the controlled release of active agents and a process for its preparation.
CA2314571A1 (en) Methods and compositions for treating diseases and conditions of the eye
GB9818973D0 (en) Method for preparing pharmaceutical formulations
US4298611A (en) Process for reducing blood pressure in animals
IE873463L (en) Compositions
BG103351A (en) Medicamentous form with extended release
IT1238210B (it) Esteri del cefamandolo nafato, procedimento per la loro preparazione erelative composizioni farmaceutiche.